|
|
||||||||
J Biol Chem, Vol. 274, Issue 44, 31593-31596, October 29, 1999
From the Department of Cell Biology, Institute of Molecular
Biology, Austrian Academy of Sciences, Billrothstrasse 11, A-5020
Salzburg, Austria
Expression of S100A6 (Calcyclin), a member of the
S100 family and of Zn2+-binding proteins is elevated
in a number of malignant tumors. In vitro the protein
associates with several actin-binding proteins and annexins in a
Ca2+-dependent manner. We have now studied the
subcellular localization of S100A6 using a new, specific monoclonal
antibody. Immunofluorescence microscopy of unfixed, ultrathin, frozen
sections demonstrated a dual localization of S100A6 at the nuclear
envelope and the plasma membrane of porcine smooth muscle only in the
presence of Ca2+. The same localization was found by
immunofluorescence and immunogold electron microscopy as well as by
confocal laser scanning microscopy with cultured, fixed, human CaKi-2
and porcine ST interphase cells. Upon cell division, however, S100A6
was found exclusively in the cytoplasm. Cell fractionation studies
showed that S100A6 was present in the microsomal fraction in the
presence of Ca2+ and was released from this fraction by the
addition of EGTA/EDTA but not by Triton X-100. The data demonstrate
that S100A6 is localized both at the plasma membrane and the nuclear
envelope in vivo and suggest a
Ca2+-dependent interaction with annexins or
other components of the nuclear envelope.
Because calcium plays a crucial role in the regulation of several
nuclear functions (1, 2), a strong interest exists in identifying
Ca2+-binding proteins involved in the perception and
transduction of signals involved in cell cycle control and cell death.
The S100 family comprises 16 closely related members, 13 of which form
a gene cluster in the epidermal differentiation complex of chromosome 1 in humans (3). S100 proteins consist of two Ca2+-binding
EF-hands and short individual N and C termini. The first EF-hand is
conserved among the S100 family and the second EF-hand follows the
canonical consensus. Almost all S100 proteins form stable homo- or
heterodimers and several members have been shown to bind
Zn2+ in addition to Ca2+ in vitro
(4). A subclass of EF-hand Ca2+-binding proteins forming
the large S100 protein family has attracted substantial interest in the
last decade due to their tissue- and cell type-specific expression
patterns and their involvement in several diseases (5). The S100 gene
products play a role in multiple proliferation- and
differentiation-related events and appear to be involved in autoimmune
diseases and cancer (6). S100B is predominantly expressed in brain and
has been implicated in Alzheimer's disease, epilepsy, and
neurodegenerative symptoms commonly associated with Down Syndrome (7).
S100A7 is overexpressed in psoriatic lesions (8), and the S100A8/A9
(MRP8/MRP14) heterodimer plays a role in inflammation and cystic
fibrosis (9) (for review see Ref. 6). In contrast to the above, S100A2
is down-regulated in breast cancer and the promotor is activated upon
the interaction with wild-type p53 (10). Thus, S100A2 was suggested to
be a tumor suppressor-related gene.
S100A6 (calcyclin) was first identified by molecular cloning of the
growth factor-inducible gene 2A9 (11). Its expression is elevated in
response to growth factor-stimulated proliferation of quiescent
fibroblasts, indicating a role in cell cycle progression (12). Further
studies showed that this elevation in expression is mediated by a
growth factor-responsive element in the promotor region of S100A6 (13)
and peaks in the transition from G0- to S-phase in
serum-stimulated quiescent smooth muscle cells (14). S100A6 was also
found to be overexpressed in several tumors like acute myeloid leukemia
(11) and neuroblastoma (15), and also in a variety of melanoma cell
lines (16). Overexpression of S100A6 correlates with the metastatic
behavior in nude mice and an up-regulated expression has also been
observed in wound healing after corneal injury (17). S100A6 was
additionally identified and purified from murine Ehrlich ascites tumor
cells (18) and Gou et al. (19) described a correlation
between the expression of S100A6 and the metastatic behavior of
Ras-transformed NIH 3T3 fibroblasts. In benign tissues, S100A6 is
expressed predominantly in fibroblasts and epithelial cells (20) but is
also present in neuronal and smooth muscle cells. To elucidate the
in vivo function(s) of S100A6 recent efforts focused on the
identification of cellular binding partners and the metal-binding
characteristics (21). Several in vitro studies revealed
Ca2+-dependent interactions with actin binding
proteins like caldesmon (22), tropomyosin (23), and calponin (24). More
recently a novel protein of yet unknown function, termed p30 or CaCYBP, has been reported to bind to S100A6 in vitro (25). In
addition, members of the annexin family were shown to interact with
S100A6 in a Ca2+-dependent manner. Thus,
affinity chromatography using immobilized calcyclin revealed an
interaction with annexin II and annexin VI (26). The interaction of
S100A6 with annexin XI has been studied in more detail, and the binding
sites on both molecules have been mapped (27). Notably, annexin XI has
been reported to target to the nucleus and to display a distinct
localization during mitosis (28).
The localization of S100A6 has been also studied in transformed (15,
29) or normal tissues (20, 30), and in cultured smooth muscle cells
(31) using a polyclonal antibody. In this study we have reinvestigated
the Ca2+-dependent subcellular localization of
S100A6 using a novel highly specific monoclonal antibody and show that
the protein localizes to the plasma membrane and the nuclear envelope
of smooth and nonmuscle cells.
All chemicals were from Merck with the exception of HEPES and
Triton X-100 (Sigma), fetal bovine serum (HyClone), Dulbecco's modified Eagle's medium and minimal essential medium (Life Technologies).
Antibodies--
Monoclonal anti-porcine calcyclin (clone
CACY-100) was from Sigma.
Ultrathin Frozen Sections--
Fresh porcine stomach smooth
muscle tissue was excised in 2 × 2 × 30 mm strips and
submerged in buffer containing 20 mM imidazole, pH 7.0, 150 mM NaCl, 5 mM MgCl2, 5% (v/v)
glycerol, 1 mM NaN3, 1 mM
phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin-pepstatin (Roche),
and 2 M sucrose as cryoprotectant at 4 °C overnight. Muscle strips were then mounted onto aluminum cryopins (Reichert) and
frozen in liquid nitrogen. Cryosections of 5-8 µm were cut using a
Reichert-Jung FC4E cryo-ultramicrotome. Sections were then transferred
to silanized coverslips, dried for 1 h at room temperature and
subjected to immunofluorescence staining.
Cell Culture and Immunofluorescence Microscopy--
Porcine
testis (ST) and human CaKi-2 cells were cultured in Dulbecco's
modified Eagle's medium supplemented with 10% fetal bovine serum at
37 °C and 5% CO2. For immunofluorescence microscopy, cells were grown on ethanol/HCl-washed 15-mm glass coverslips. Cells on
coverslips were rinsed in
HBS1 (10 mM
HEPES, pH 7.4, 135 mM NaCl, 15 mM KCl, 5 mM MgCl2), fixed for 20 min with 3.7%
paraformaldehyde in HBS and permeabilized with 0.3% Triton X-100 in
3.7% paraformaldehyde in HBS for 5 min. All steps were carried out in
the presence of either 2 mM CaCl2, 2 mM ZnCl2, or 5 mM EGTA. After
blocking with 1 mg/ml bovine serum albumin and 5% donor horse serum in
HBS for 30 min, cells were incubated with monoclonal anti-S100A6
antibody (clone CACY-100), followed by incubation with secondary
Cy-3-labeled (Sigma) or biotinylated (Dako) goat anti-mouse IgG
antibody and Cy-2 streptavidin (Fluorolink). Coverslips were washed and
mounted in Gelvatol containing 2.5 mg/ml n-propylgallate.
All steps were carried out in the presence of either 2 mM
CaCl2 or 5 mM EGTA. Fluorescent images were
recorded on a Zeiss Axiophot using a 63× (nominal aperture 1.4) oil
immersion lens and Kodak P3200 Tmax film. Confocal microscopy was
performed on a Bio-Rad MRC-1024 model using a Zeiss 63× (nominal
aperture 1.2) C-apochromat water immersion lens.
Cell Fractionation, Electrophoresis, and Western
Blotting--
Cells (porcine ST and human CaKi-2) were grown to 90%
confluence in 10-cm tissue culture Petri dishes (Falcon), washed in HBS
and harvested in 2 ml of HBS with a tissue culture scraper. For
harvesting the cells and all following steps, the HBS contained either
2 mM CaCl2 or 5 mM EGTA, with or
without 0.5% Triton X-100. The suspension was homogenized with a
glass-glass tissue grinder and fractionated by ultracentrifugation for
30 min at 100,000 × g (Sorvall, RC M150 GX) at
4 °C. The pellet was washed by resuspension in HBS and
ultracentrifugation was repeated. All samples were precipitated with
methanol/chloroform following the method of Wessel and Flugge (32) and
resuspended in SDS sample buffer, and an equivalent of 2 cm2 of cells was applied to the gel. Analytical SDS gel
electrophoresis on 10-26% gradient polyacrylamide mini-slab gels and
Western blotting onto nitrocellulose (Hybond, Amersham Pharmacia
Biotech) was performed as described elsewere (33). Transferred proteins
reactive with the monoclonal anti-S100A6 antibody were visualized using
horseradish peroxidase-coupled secondary antibodies and the ECL
chemiluminescence system (Amersham Pharmacia Biotech).
Electron Microscopy--
Nuclei of cultured pig ST cells were
isolated as described by Kihlmark and Hallberg (34), resuspended in HBS
containing phenylmethylsulfonyl fluoride, pepstatin-leupeptin, and
0.05% Triton X-100, incubated on ice for 5 min, and pelleted by
centrifugation. The pellet was resuspended in HBS containing 1 mg/ml
bovine serum albumin and incubated with the monoclonal anti-S100A6
antibody for 1 h at room temperature. After washing the nuclei 3 times in HBS they were incubated with a 10-nm gold-labeled secondary antibody (BioCell) for 45 min at room temperature, washed 3 times and
fixed in 3.7% paraformaldehyde , 2.5% glutaraldehyde in HBS for 15 min. The blocks were dehydrated in ethanol and embedded in Araldite
(TAAB). Ultrathin sections were stained with uranyl acetate and lead
citrate and viewed in a Zeiss EM 10A electron microscope.
A monoclonal antibody specific for S100A6 was generated as
described earlier (35) using porcine smooth muscle S100 proteins as the
antigen. Clone CACY-100 specifically recognizes S100A6 but not S100A2
or S100b on Western blots of whole cell and tissue extracts (Fig.
1).
We first determined the subcellular localization of S100A6 in unfixed,
frozen sections of porcine stomach smooth muscle. In the presence of
Ca2+, S100A6 displayed a dual localization, on the plasma
membrane and in the nucleus. Longitudinal sections revealed an
association along thin thread-like structures (Fig.
2A), which correlated with the
punctate pattern around the cell periphery seen in cross sections (Fig.
2B). Labeling in the nucleus was confirmed by
counterstaining for nucleic acids and higher resolution images revealed
a ring-like structure, indicating that S100A6 is localized at the
nuclear envelope, but not inside the nucleus (Fig. 2C).
Incubation of unfixed tissue sections with buffer containing chelating
agents resulted in the complete loss of the fluorescent signal (data not shown).
Ca2+-dependent Association of S100A6
(Calcyclin) with the Plasma Membrane and the Nuclear Envelope*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (74K):
[in a new window]
Fig. 1.
Specificity of monoclonal anti-S100A6
antibody. Coomassie Blue-stained polyacrylamide gel
electrophoresis gel (A) and corresponding Western blot
(B) showing the reactivity of monoclonal antibody clone
CACY-100. The antibody specifically recognizes recombinant (lane
1) and native porcine S100A6 (lane 9), detects S100A6
in whole cell extracts of porcine ST (lane 3), porcine LLC
PK1 (lane 4), or human CaKi-2 cells (lane 5), and
in tissue extracts of porcine stomach (lane 6) and porcine
uterus (lane 7) smooth muscle but is not reactive with
either recombinant S100A2 (lane 2) or native S100b from
bovine brain (lane 8). Note the reactivity of the antibody
with both monomer (M) and the stable dimer (D) in
purified native S1006 (lane 9). Position of molecular weight
markers is indicated in panel A.

View larger version (59K):
[in a new window]
Fig. 2.
Localization of S100A6 in porcine smooth
muscle. Unfixed ultrathin frozen longitudinal sections
(A) and cross sections (B) stained with antibody
CACY-100 in the presence of Ca2+. C, higher
contrast image of a cross section reveals concentration of S100A6
around the nuclear envelope.
These data suggested that S100A6 colocalizes with two membranous
cellular compartments, namely the plasma membrane and the nuclear
envelope of smooth muscle cells in a
Ca2+-dependent manner. To support the results
obtained with unfixed tissue sections, we next studied the distribution
of S100A6 in cultured porcine ST cells fixed and labeled both in the
presence or absence of divalent cations. In the presence of
Ca2+, staining of the plasma membrane was observed in cells
extracted with 0.1% Triton X-100 (Fig.
3A). When the Triton X-100
concentration was increased to 0.3%, localization at the plasma
membrane was lost and a weak cytoplasmic distribution in addition to a
strong concentration in the nucleus was observed. Notably, in the
presence of Zn2+, S100A6 localization was indistinguishable
from that seen in cells stained in the absence of both Ca2+
and EGTA/EDTA (Fig. 3B). In the presence of chelating agents like EGTA and EDTA S100A6 localization was detected only in the nucleus
(Fig. 3C). Identical results were obtained in the human cell
line CaKi-2 indicating that the observed localization pattern reflects
the position of endogenous S100A6 (not shown), and in agreement with
these data Brink et al. (29) and Mandinova et al.
(31) likewise reported partial nuclear localization of S100A6 in human
cells and tissues. In mitotic cells, S100A6 is distributed throughout
the cytoplasm but is absent from regions of condensed chromatin (Fig.
3B, arrowheads). Staining of mitotic and
interphase cells using an anti-lamin A antibody resulted in patterns
similar to those obtained with the S100A6 antibody (not shown).
|
Confocal laser scanning microscopy was used to further confirm the dual
localization of S100A6 at the plasma membrane and the nuclear envelope.
Cells were extracted with 0.1% Triton X-100 in the presence of
Ca2+ and examined by confocal microscopy in the
x-z axis. As seen in Fig.
4, A and B, the
antibody CACY-100 revealed the presence of S100A6 at the plasma
membrane and to a lesser extent in the cytoplasm. We interpret the lack
of fluorescent signal at the nuclear envelope as an indication for the
inaccessibility of the antibody epitope under these gentle extraction
procedures. This conclusion was supported by the results of sections
and three-dimensional reconstructions of confocal images from cells
extracted in the presence of 0.3% Triton X-100, which showed a
specific association of S100A6 with the nuclear envelope (Fig. 4,
C and D).
|
In contrast to the results obtained with unfixed tissue sections,
S100A6 remained associated with the nuclear envelope of fixed cultured
cells even in the presence of EGTA/EDTA. Together with the observed
requirement for increased Triton X-100 concentrations, these data
strongly suggest that S100A6 localizes at the inner face of the nuclear
envelope and that this binding is mediated via a binding partner, which
is sensitive to formaldehyde fixation. We therefore used immunogold
electron microscopy on isolated nuclei to further test the hypothesis
that S100A6 colocalized with inner structures of the nuclear envelope.
The nuclear envelope consists of three compartments, the outer nuclear
membrane, the inner membrane, and the lamina. As expected, gold
particles were detected exclusively in the space between the outer and
the inner nuclear membrane, and in the vicinity of the nuclear lamina
(Fig. 5).
|
Both fluorescence and electron microscopy suggested a membrane
association of S100A6 requiring the presence Ca2+. To
further support this conclusion, we carried out cell fractionations. As
seen in Fig. 6, S100A6 was detected in
the microsomal fraction of cultured porcine ST cells by Western
blotting, and this association was strictly
Ca2+-dependent. S100A6 was released from the
pellet upon addition of EGTA/EDTA. In contrast, the addition of 0.5%
Triton X-100 to the extraction buffer failed to solubilize S100A6.
However, significant amounts of S100A6 were also found in the soluble
fraction, in agreement with the results obtained in the microscopic
studies. These data also support previous studies by Lesniak and
Filipek (36) that demonstrated the
Ca2+-dependent interaction of S100A6 with
microsomal membranes from murine Ehrlich ascites tumor cells.
|
Taken together, our data suggest that S100A6 is located in the cytoplasm and is targeted to two membranous compartments, namely the plasma membrane and the nuclear envelope upon the increase of cytoplasmic Ca2+, mediated by yet unidentified signals. The variable extractability of S100A6 associated with the plasma membrane versus the nuclear envelope points to an interaction of S100A6 with two different targets. Interaction with the plasma membrane was strongly dependent on the presence of Ca2+ but was lost upon the addition of Triton X-100 despite fixation with paraformaldehyde. The interaction with the Triton X-100 insoluble fraction, i.e. the nuclear envelope, likewise depended on the presence of Ca2+, as shown in the cell fractionation experiments and in unfixed tissue sections, but S100A6 remained firmly attached to its putative target after fixation even in the presence of EGTA. In contrast, cytoplasmic S100A6 was extracted in the presence and absence of Ca2+ despite prior fixation with formaldehyde. Interestingly, several S100 proteins have been shown recently to interact directly with intermediate filament proteins (37). Thus, the association of S100A6 with the intermediate filaments of the nuclear lamina is plausible.
The potential binding partners for S100A6 that have thus far been
identified can be divided into two groups, one comprising several
actin-binding proteins, and the second embracing members of the annexin
family. In this study we failed to detect any colocalization of S100A6
with actin-rich structures, although an interaction with components of
the actin cytoskeleton cannot be ruled out completely. Annexin II and
annexin VI were described to interact with S100A6 and have been shown
to colocalize with the plasma membrane (38). Barwise and Walker (38)
demonstrated that annexin II relocates to granular structures at the
plasma membrane, whereas annexin VI adopts a more homogeneous
distribution at the plasma membrane in cells treated with the calcium
ionophore A23187. More importantly, this group also claimed that the
intranuclear portion of annexins IV and V translocates to the nuclear
membrane under the same conditions. Likewise, annexin XI displays
partial nuclear localization and is one of the potential targets of
S100A6. The binding sites of both molecules have been mapped within
residues 4-7 in S100A6 (39) and residues 52-59 in annexin XI (27), respectively. Furthermore annexin XI has been reported to alter its
localization during mitosis, forming an arc-like structure around the
mitotic spindle (28). Our results indicate that S100A6 is localized at
multiple discrete sites in the cell including the inner face of the
nuclear envelope and that the protein undergoes specific translocations
during mitosis. The colocalization of S100A6 with these membranous
compartments is strictly dependent on the presence of Ca2+
and is likely to correspond to the sites of functionally active S100A6.
From these data we therefore suggest an interaction of S100A6 in
vivo with members of the annexin family, and in particular with
nuclear annexin XI. Moreover, we have shown that refined methods are
required to reveal the localization of S100A6 at multiple distinct
compartments in the cell. Our further efforts are directed toward
characterizing the interaction between S100A6 and annexin XI in
vitro and in vivo.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Dr. K. I. Anderson (Marie Curie Institute, Oxted, United Kingdom) for confocal microscopy, Prof. J. V. Small for help with electron microscopy and valuable comments on the manuscript, and U. Müller and M. Schmittner for technical assistance and photography.
| |
FOOTNOTES |
|---|
* This work was supported by the Austrian Science Foundation (P-11845).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 43-662-63961-19;
Fax: 43-662-63961-40; E-mail:
mgimona@server1.imolbio.oeaw.ac.at.
| |
ABBREVIATIONS |
|---|
The abbreviation used is: HBS, HEPES-buffered saline.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Gilchrist, J. S., Czubryt, M. P., and Pierce, G. N. (1994) Mol. Cell. Biochem. 135, 79-88[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Carafoli, E., Nicotera, P., and Santella, L. (1997) Cell Calcium 22, 313-319[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Volz, A., Korge, B. P., Compton, J. G., Ziegler, A., Steinert, P. M., and Mischke, D. (1993) Genomics 18, 92-95[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Heizmann, C. W., and Cox, J. A. (1998) Biometals 11, 383-397[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Kligman, D., and Hilt, D. C. (1988) Trends Biochem. Sci. 13, 437-443[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Schafer, B. W., and Heizmann, C. W. (1996) Trends Biochem. Sci. 21, 134-140[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Marks, A., and Allore, R. (1990) Bioessays 12, 381-383[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Watson, P. H., Leygue, E. R., and Murphy, L. C. (1998) Int. J. Biochem. Cell Biol. 30, 567-571[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Kerkhoff, C., Klempt, M., and Sorg, C. (1998) Biochim. Biophys. Acta 1448, 200-211[Medline] [Order article via Infotrieve] |
| 10. | Tan, M., Heizmann, C. W., Guan, K., Schafer, B. W., and Sun, Y. (1999) FEBS Lett. 445, 265-268[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Calabretta, B.,
Kaczmarek, L.,
Mars, W.,
Ochoa, D.,
Gibson, C. W.,
Hirschhorn, R. R.,
and Baserga, R.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
4463-4467 |
| 12. |
Calabretta, B.,
Battini, R.,
Kaczmarek, L.,
de Riel, J. K.,
and Baserga, R.
(1986)
J. Biol. Chem.
261,
12628-12632 |
| 13. | Ghezzo, F., Valpreda, S., De Riel, J. K., and Baserga, R. (1989) DNA 8, 171-177[Medline] [Order article via Infotrieve] |
| 14. | Kindy, M. S., Brown, K. E., and Sonenshein, G. E. (1991) J. Cell. Biochem. 46, 345-350[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Tonini, G. P., Fabretti, G., Kuznicki, J., Massimo, L., Scaruffi, P., Brisigotti, M., and Mazzocco, K. (1995) Eur. J. Cancer 31A, 499-504 |
| 16. |
Weterman, M. A.,
Stoopen, G. M.,
van Muijen, G. N.,
Kuznicki, J.,
Ruiter, D. J.,
and Bloemers, H. P.
(1992)
Cancer Res.
52,
1291-1296 |
| 17. | Bazan, H. E., Allan, G., and Bazan, N. G. (1992) Exp. Eye Res. 55, 173-177[Medline] [Order article via Infotrieve] |
| 18. | Kuznicki, J., Filipek, A., Hunziker, P. E., Huber, S., and Heizmann, C. W. (1989) Biochem. J. 263, 951-956[Medline] [Order article via Infotrieve] |
| 19. | Guo, X. J., Chambers, A. F., Parfett, C. L., Waterhouse, P., Murphy, L. C., Reid, R. E., Craig, A. M., Edwards, D. R., and Denhardt, D. T. (1990) Cell Growth Differ. 1, 333-338[Abstract] |
| 20. | Kuznicki, J., Kordowska, J., Puzianowska, M., and Wozniewicz, B. M. (1992) Exp. Cell Res. 200, 425-430[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Kordowska, J., Stafford, W. F., and Wang, C. L. (1998) Eur. J. Biochem. 253, 57-66[Medline] [Order article via Infotrieve] |
| 22. |
Mani, R. S.,
and Kay, C. M.
(1995)
J. Biol. Chem.
270,
6658-6663 |
| 23. | Golitsina, N. L., Kordowska, J., Wang, C. L., and Lehrer, S. S. (1996) Biochem. Biophys. Res. Commun. 220, 360-365[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Wills, F. L., McCubbin, W. D., Gimona, M., Strasser, P., and Kay, C. M. (1994) Protein Sci. 3, 2311-2321[Abstract] |
| 25. | Filipek, A., and Kuznicki, J. (1998) J. Neurochem. 70, 1793-1798[Medline] [Order article via Infotrieve] |
| 26. | Zeng, F. Y., Gerke, V., and Gabius, H. J. (1993) Int. J. Biochem. 25, 1019-1027[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Sudo, T.,
and Hidaka, H.
(1998)
J. Biol. Chem.
273,
6351-6357 |
| 28. |
Mizutani, A.,
Usuda, N.,
Tokumitsu, H.,
Minami, H.,
Yasui, K.,
Kobayashi, R.,
and Hidaka, H.
(1992)
J. Biol. Chem.
267,
13498-13504 |
| 29. | Brinck, U., Gabius, H. J., Zeng, F. Y., Gerke, V., Lazarou, D., Zografakis, C., Tsambaos, D., and Berger, H. (1995) J. Dermatol. Sci. 10, 181-190[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Yamashita, N., Ilg, E. C., Schafer, B. W., Heizmann, C. W., and Kosaka, T. (1999) J. Comp. Neurol. 404, 235-257[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Mandinova, A., Atar, D., Schafer, B. W., Spiess, M., Aebi, U., and Heizmann, C. W. (1998) J. Cell Sci. 111, 2043-2054[Abstract] |
| 32. | Wessel, D., and Flugge, U. I. (1984) Anal. Biochem. 138, 141-143[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Gimona, M., Herzog, M., Vandekerckhove, J., and Small, J. V. (1990) FEBS Lett. 274, 159-162[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Kihlmark, M., and Hallberg, E. (1988) in Cell Biology: A Laboratory Manual 2nd Ed. (Celis, J. E., ed) , pp. 152-158, Academic Press, San Diego, CA |
| 35. | Gimona, M., Lando, Z., Dolginov, Y., Vandekerckhove, J., Kobayashi, R., Sobieszek, A., and Helfman, D. M. (1997) J. Cell Sci. 110, 611-621[Abstract] |
| 36. | Lesniak, W., and Filipek, A. (1996) Biochem. Biophys. Res. Commun. 220, 269-273[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Garbuglia, M., Verzini, M., and Donato, R. (1998) Cell Calcium 24, 177-191[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Barwise, J. L., and Walker, J. H. (1996) J. Cell Sci. 109, 247-255[Abstract] |
| 39. | Watanabe, M., Ando, Y., Tokumitsu, H., and Hidaka, H. (1993) Biochem. Biophys. Res. Commun. 196, 1376-1382[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
L. M. Orre, M. Pernemalm, J. Lengqvist, R. Lewensohn, and J. Lehtio Up-regulation, Modification, and Translocation of S100A6 Induced by Exposure to Ionizing Radiation Revealed by Proteomics Profiling Mol. Cell. Proteomics, December 1, 2007; 6(12): 2122 - 2131. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Farnaes and H. J. Ditzel Dissecting the Cellular Functions of Annexin XI Using Recombinant Human Annexin XI-specific Autoantibodies Cloned by Phage Display J. Biol. Chem., August 29, 2003; 278(35): 33120 - 33126. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tomas and S. E. Moss Calcium- and Cell Cycle-dependent Association of Annexin 11 with the Nuclear Envelope J. Biol. Chem., May 23, 2003; 278(22): 20210 - 20216. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Adam, R. Boyd, K. L. Tyson, G. C. Fletcher, A. Stamps, L. Hudson, H. R. Poyser, N. Redpath, M. Griffiths, G. Steers, et al. Comprehensive Proteomic Analysis of Breast Cancer Cell Membranes Reveals Unique Proteins with Potential Roles in Clinical Cancer J. Biol. Chem., February 14, 2003; 278(8): 6482 - 6489. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Courtois-Coutry, C. Le Moellic, S. Boulkroun, M. Fay, F. Cluzeaud, B. Escoubet, N. Farman, and M. Blot-Chabaud Calcyclin Is an Early Vasopressin-induced Gene in the Renal Collecting Duct. ROLE IN THE LONG TERM REGULATION OF ION TRANSPORT J. Biol. Chem., July 5, 2002; 277(28): 25728 - 25734. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Filipek, B. Jastrzebska, M. Nowotny, K. Kwiatkowska, M. Hetman, L. Surmacz, E. Wyroba, and J. Kuznicki Ca2+-dependent Translocation of the Calcyclin-binding Protein in Neurons and Neuroblastoma NB-2a Cells J. Biol. Chem., May 31, 2002; 277(23): 21103 - 21109. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-L. Hsieh, B. W. Schafer, J. A. Cox, and C. W. Heizmann S100A13 and S100A6 exhibit distinct translocation pathways in endothelial cells J. Cell Sci., January 8, 2002; 115(15): 3149 - 3158. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Stradal, H. Troxler, C. W. Heizmann, and M. Gimona Mapping the Zinc Ligands of S100A2 by Site-directed Mutagenesis J. Biol. Chem., April 28, 2000; 275(18): 13219 - 13227. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |